Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05943119 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery

Study acronym: SinocaRT
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv6
  2. Secondary endpoints expanded, about 31 wordsv5
  3. Eligibility criteria shortened, about 2 wordsv4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 2024 to Mar 11, 2024
    • Site details revised at 3 of 3 sites
    v3
  5. Start date: Sep 2023 to Feb 2024
    • Interventions: RCMI in painting dose on histoscannographic mapping (Radiation), Standard pan-sinusal IMRT (Radiation) to Radiotherapy in painting dose on histoscannographic mapping (Radiation), Standard pan-sinusal Radiotherapy (Radiation)
    • Eligibility criteria expanded, about 3 words
    • Study title shortened, about 3 words
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The patient is randomized to one of the following groups: * Experimental group: Radiotherapy in painting dose on histoscannographic mapping * Control group: standard pan-sinus radiotherapy
Trial Details
NCT Number NCT05943119
Lead Sponsor Centre Francois Baclesse
Conditions
(from sponsor)		 Tumor, Solid
Related terms Fistula, Neoplasms
Enrollment 52 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov